Global Malaria Vaccine Market to Grow at 34% During 2022-2030, Propelled by Rising Prevalence of Malaria

December 01, 2022

IMARC Group’s latest report, titled “Malaria Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2030,” finds that the global malaria vaccine market is anticipated to exhibit a CAGR of around 34% during 2022-2030. Malaria vaccines are biological components that promote the formation of antibodies to reduce the risk of developing malaria, a disease caused by the plasmodium parasite, which is spread to humans through the bites of infected mosquitoes. It is generally characterized by headaches, chills, fever, fatigue, nausea, and other symptoms. Some commonly used malaria vaccines include pre-erythrocytic, erythrocytic, and multi-antigen vaccines. They can be administered through intramuscular, subcutaneous, and intradermal injections. In recent years, malaria vaccines have gained immense traction across the globe to prevent the risk of contracting malaria. 

Global Malaria Vaccine Market Trends:

The rising prevalence of malaria, especially across tropical countries, represents the primary factor driving the market growth. Moreover, the development of anti-infective or pre-erythrocytic vaccines that kill the plasmodium parasite and prevent the progression of chronic blood-stage disorders is positively influencing market growth. Additionally, numerous favorable initiatives by various government and non-government organizations to spread awareness about the importance of immunization and disease prevention among the masses are other major growth-inducing factors. Along with this, the increasing number of routine immunization programs in various countries, particularly in the endemic and rural regions, is propelling the market growth. Besides this, the rising focus of pharmaceutical companies on the development of new and improved malaria vaccines by accelerating the clinical trials of various pipeline drugs has catalyzed market growth. Furthermore, numerous technological advancements, including the introduction of novel adjuvants and innovative vaccination delivery platforms, are contributing to the market growth. Other factors, including ongoing research and development (R&D) activities, the launch of innovative product variants, extensive investments in improving healthcare infrastructure, and increasing funding for vaccine development programs, are also anticipated to create a favorable market outlook. 

Market Summary:

  • Based on the type, the market has been divided into pre-erythrocytic, erythrocytic, multi-antigen, and other vaccines. 
  • On the basis of the agent, the market has been segmented into Plasmodium Falciparum, Plasmodium Vivax, and Anopheles Species. 
  • The market has been segregated based on the route of administration into intramuscular, subcutaneous, intradermal, and others.
  • Based on the distribution channel, the market has been categorized into NGO/non-profit organization, hospital pharmacy, retail pharmacy, online pharmacy, and others. 
  • Region-wise, the market has been divided into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa. 
  • The competitive landscape of the market has also been examined, along with the detailed profiles of key players operating in the industry.
     

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Malaria Vaccine Market to Grow at 34% During 2022-2030, Propelled by Rising Prevalence of Malaria
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More